13G Filing: Cormorant Global Healthcare Master Fund and Proteostasis Therapeutics, Inc. (PTI)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Name	Shared Voting Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Cormorant Global Healthcare Master Fund	1,450,825	1,450,825	1,450,825	7.6%
Cormorant Global Healthcare GP	1,450,825	1,450,825	1,450,825	7.6%
Cormorant Asset Management	1,725,460	1,725,460	1,725,460	9.0%
Bihua Chen	1,725,460	1,725,460	1,725,460	9.0%

[ ] Rule 13d-1(b)

[x] Rule 13d-1(c)

[ ] Rule 13d-1(d)

___________________________________

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

13G Filing: Cormorant Global Healthcare Master Fund and Proteostasis Therapeutics, Inc. (PTI)

Published on March 2, 2016 at 5:21 pm by Meena Krishnamsetty in Hedge Funds

Ownership Summary Table

Page 1 of 8 SEC Filing

Follow Kineta Inc. (NASDAQ:KA)

Follow Kineta Inc. (NASDAQ:KA)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff

	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
		OMB Number:3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4

	SCHEDULE 13G
	Under the Securities Exchange Act of 1934
	(Amendment No. ___)*

	Common Stock, par value $0.001 per share
	(Title of Class of Securities)

	February 16, 2016
	(Date of Event which Requires Filing of this Statement)

	74373B109
	(CUSIP Number)